Close Menu

NEW YORK (GenomeWeb) – Sequenom today reported preliminary 2015 revenue of $128 million, below analyst estimates of $130 million.

The company also said it accessioned 42,000 total commercial diagnostic test samples in the fourth quarter, up from 41,000 in the third quarter. Of the 42,000 tests, 37,300 were noninvasive prenatal test samples. In addition, Sequenom accessioned 3,000 of its MaterniT Genome test in Q4, the assay's first full quarter of sales.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports that the US Department of Agriculture told its researchers to label peer-reviewed articles as "preliminary" work.

Australia will not be regulating gene editing of plants, animals, and human cell lines as long as no new genetic material is incorporated, reports Nature News.

Researchers have sequenced the genomes of both the coast redwood and the giant sequoia, according to the San Francisco Chronicle.

In PNAS this week: study of epigenetic patterns in mammalian eggs, clonal expansion patterns in CD8+ T cells, and more.